Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease — Stella

Recruiting

Back to Diabetic Retinopathy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Wilmer Eye Institute, Baltimore, Maryland

Key details

Sponsor

Johns Hopkins University

Collaborators

National Eye Institute (NEI)

Enrollment target

~1,050 participants

Started

October 2019

Primary completion

June 2026

Age range

18 Years – 99 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov